MURALI DORAISWAMY, M.D.
Director of the Neurocognitive Disorders Program in the Department of Psychiatry at Duke University Medical Center
Dr. Murali Doraiswamy is a Professor of Translational Neuroscience as well as Director of the Neurocognitive Disorders Program in the Department of Psychiatry at Duke University Medical Center. He also serves on the Executive Committee of the Duke Institute for Brain Sciences and as a Senior Fellow at the Duke Center for the Study of Aging. Dr. Doraiswamy directs a leading clinical trials unit which has been involved in the development of many of the leading products used today to treat cognitive and neuropsychiatric conditions. He is also widely recognized for his work in the study of imaging biomarkers (such as MRI volumetrics, amyloid PET and functional MRI). Dr. Doraiswamy is a Fellow of the Royal College of Physicians (London), a Fellow of the American Neurological Association and a member of the World Economic Forum’s Global Agenda Council on Brain research. He also serves as an Alzheimer’s adviser to leading government agencies, biotech and health companies, and patient Alzheimer’s advocacy groups.
Dr. Doraiswamy is a brain health Alzheimer’s adviser for Men’s Health magazine and serves as an Alzheimer’s advisor for AARP. He is co-author of a popular book, The Alzheimer’s Action Plan.